We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks Market Edge Highlights: Wingstop, Super Micro Computer, Medpace, Him & Hers Health and Vita Coco
Read MoreHide Full Article
For Immediate Release
Chicago, IL – May 24, 2024 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: https://www.zacks.com/stock/news/2278244/5-top-ranked-strong-buy-growth-stocks-for-2024)
5 Top-Ranked Strong Buy Growth Stocks for 2024
Welcome to Episode #402 of the Zacks Market Edge Podcast.
(0:45) - Stock Screener For Strong Growth Stocks
(4:10) - Top Investments To Keep On Your Watchlist
Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds, and ETFs and how it impacts your life.
This week she has gone solo to screen for the stocks everyone wants right now: Zacks top ranked growth stocks.
Screening for #1 Growth Stocks
What does that mean? The stock must have the Zacks Rank of #1 which is Zacks top rank of Strong Buy. On any given day, only about 220 to 240 stocks have this prestigious Zacks Rank out of over 4,000 stocks.
The Strong Buy Zacks Rank usually indicates the analysts are raising earnings estimates. Why should we care about that? Because it usually means there is something good going on at the company if all the analysts are revising higher for the full year.
The screen also looks for double digit growth for last year and this year. That means the company isn't just a flash in the pan. It has a 2-year track record.
Wingstop has been a growth machine throughout the pandemic and now post-pandemic. First quarter domestic same-store-sales skyrocketed 21.6% with much of the growth from transactions, not from price increases.
Wingstop is expected to grow earnings in 2024 by 36.7%. Shares of Wingstop are up 87% over the last year compared to the S&P 500 which is just up 26.8%.
Super Micro Computer has been one of the big AI and data center winners of the last year. Earnings are expected to jump 99% this fiscal year thanks to the AI revolution.
Shares of Super Micro Computer have soared 430% in the last year but have pulled back from all-time highs.
Should investors be buying Super Micro Computer instead of other AI names like NVIDIA?
Medpace is a clinical contract research company that provides Phase I-IV clinical development services. First quarter revenue was up 17.7% while Medpace's net new business awards rose 10.8%.
Shares of Medpace are up 86% in the last year. Earnings are expected to rise 27% this year.
Should a medical services #1 Rank stock like Medpace be on your short list?
Him & Hers Health operates a health and wellness platform which saw subscribers jump 41% to 1.7 million in the first quarter of 2024. Free cash flow was $11.9 million in the first quarter, up from $7 million last year.
Shares of Him & Hers Health have taken off in 2024, gaining 70.2% over the last year. Earnings are expected to soar 263% to $0.18 from a loss of $0.11 last year.
Is Him & Hers Health the next great subscription business?
The Vita Coco Company makes healthy, nutritious beverages including coconut water. It has no debt and had cash on hand as of Mar 31, 2024 of $122 million.
Shares of Vita Coco have been subdued over the last year, rising just 0.04%. But on the two-year stack, Vita Coco is up 148.8%. Earnings are expected to rise 40.8% this year.
Is this a buying opportunity in Zacks #1 Rank (Strong Buy) Vita Coco?
What Else Should You Know About these Strong Buy Stocks?
Tune into this week's video podcast to find out.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks Market Edge Highlights: Wingstop, Super Micro Computer, Medpace, Him & Hers Health and Vita Coco
For Immediate Release
Chicago, IL – May 24, 2024 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: https://www.zacks.com/stock/news/2278244/5-top-ranked-strong-buy-growth-stocks-for-2024)
5 Top-Ranked Strong Buy Growth Stocks for 2024
Welcome to Episode #402 of the Zacks Market Edge Podcast.
Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds, and ETFs and how it impacts your life.
This week she has gone solo to screen for the stocks everyone wants right now: Zacks top ranked growth stocks.
Screening for #1 Growth Stocks
What does that mean? The stock must have the Zacks Rank of #1 which is Zacks top rank of Strong Buy. On any given day, only about 220 to 240 stocks have this prestigious Zacks Rank out of over 4,000 stocks.
The Strong Buy Zacks Rank usually indicates the analysts are raising earnings estimates. Why should we care about that? Because it usually means there is something good going on at the company if all the analysts are revising higher for the full year.
The screen also looks for double digit growth for last year and this year. That means the company isn't just a flash in the pan. It has a 2-year track record.
This screen returned 52 stocks.
5 Top Ranked Strong Buy Growth Stocks for 2024
1. Wingstop Inc. (WING - Free Report)
Wingstop has been a growth machine throughout the pandemic and now post-pandemic. First quarter domestic same-store-sales skyrocketed 21.6% with much of the growth from transactions, not from price increases.
Wingstop is expected to grow earnings in 2024 by 36.7%. Shares of Wingstop are up 87% over the last year compared to the S&P 500 which is just up 26.8%.
Should Wingstop be on your short list?
2. Super Micro Computer, Inc. (SMCI - Free Report)
Super Micro Computer has been one of the big AI and data center winners of the last year. Earnings are expected to jump 99% this fiscal year thanks to the AI revolution.
Shares of Super Micro Computer have soared 430% in the last year but have pulled back from all-time highs.
Should investors be buying Super Micro Computer instead of other AI names like NVIDIA?
3. Medpace Holdings, Inc. (MEDP - Free Report)
Medpace is a clinical contract research company that provides Phase I-IV clinical development services. First quarter revenue was up 17.7% while Medpace's net new business awards rose 10.8%.
Shares of Medpace are up 86% in the last year. Earnings are expected to rise 27% this year.
Should a medical services #1 Rank stock like Medpace be on your short list?
4. Him & Hers Health, Inc. (HIMS - Free Report)
Him & Hers Health operates a health and wellness platform which saw subscribers jump 41% to 1.7 million in the first quarter of 2024. Free cash flow was $11.9 million in the first quarter, up from $7 million last year.
Shares of Him & Hers Health have taken off in 2024, gaining 70.2% over the last year. Earnings are expected to soar 263% to $0.18 from a loss of $0.11 last year.
Is Him & Hers Health the next great subscription business?
5. The Vita Coco Company, Inc. (COCO - Free Report)
The Vita Coco Company makes healthy, nutritious beverages including coconut water. It has no debt and had cash on hand as of Mar 31, 2024 of $122 million.
Shares of Vita Coco have been subdued over the last year, rising just 0.04%. But on the two-year stack, Vita Coco is up 148.8%. Earnings are expected to rise 40.8% this year.
Is this a buying opportunity in Zacks #1 Rank (Strong Buy) Vita Coco?
What Else Should You Know About these Strong Buy Stocks?
Tune into this week's video podcast to find out.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch/
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com/performance
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.